Gene Therapy for Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is a devastating, aggressive primary brain tumor with poor patient outcomes and a five-year survival of less than 10%. Significant limitations to effective GBM treatment include poor drug delivery across the blood–brain barrier, drug resistance, and complex genetic tumo...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2025-01-01
|
| Серія: | Viruses |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1999-4915/17/1/118 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|